 Connection
Mary Sammel to Abortifacient Agents, Nonsteroidal
This is a "connection" page, showing publications Mary Sammel has written about Abortifacient Agents, Nonsteroidal.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.547 |
|
|
|
-
Barnhart KT, Gosman G, Ashby R, Sammel M. The medical management of ectopic pregnancy: a meta-analysis comparing "single dose" and "multidose" regimens. Obstet Gynecol. 2003 Apr; 101(4):778-84.
Score: 0.213
-
Roe AH, Abernathy A, Flynn AN, McAllister A, Koelper NC, Sammel MD, Schreiber CA, Sonalkar S. Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss. Obstet Gynecol. 2022 06 01; 139(6):1149-1151.
Score: 0.200
-
Barnhart KT, Hansen KR, Stephenson MD, Usadi R, Steiner AZ, Cedars MI, Jungheim ES, Hoeger KM, Krawetz SA, Mills B, Alston M, Coutifaris C, Senapati S, Sonalkar S, Diamond MP, Wild RA, Rosen M, Sammel MD, Santoro N, Eisenberg E, Huang H, Zhang H. Effect of an Active vs Expectant Management Strategy on Successful Resolution of Pregnancy Among Patients With a Persisting Pregnancy of Unknown Location: The ACT or NOT Randomized Clinical Trial. JAMA. 2021 08 03; 326(5):390-400.
Score: 0.190
-
Flynn AN, Roe AH, Koelper N, McAllister A, Sammel MD, Schreiber CA. Timing and efficacy of mifepristone pretreatment for medical management of early pregnancy loss. Contraception. 2021 06; 103(6):404-407.
Score: 0.183
-
Sonalkar S, Koelper N, Creinin MD, Atrio JM, Sammel MD, McAllister A, Schreiber CA. Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial. Am J Obstet Gynecol. 2020 10; 223(4):551.e1-551.e7.
Score: 0.174
-
Alur-Gupta S, Cooney LG, Senapati S, Sammel MD, Barnhart KT. Two-dose versus single-dose methotrexate for treatment of ectopic pregnancy: a meta-analysis. Am J Obstet Gynecol. 2019 08; 221(2):95-108.e2.
Score: 0.159
-
Barnhart KT, Sammel MD, Stephenson M, Robins J, Hansen KR, Youssef WA, Santoro N, Eisenberg E, Zhang H. Optimal treatment for women with a persisting pregnancy of unknown location, a randomized controlled trial: The ACT-or-NOT trial. Contemp Clin Trials. 2018 10; 73:145-151.
Score: 0.156
-
Mergenthal MC, Senapati S, Zee J, Allen-Taylor L, Whittaker PG, Takacs P, Sammel MD, Barnhart KT. Medical management of ectopic pregnancy with single-dose and 2-dose methotrexate protocols: human chorionic gonadotropin trends and patient outcomes. Am J Obstet Gynecol. 2016 Nov; 215(5):590.e1-590.e5.
Score: 0.133
-
McLaren JF, Barnhart KT, Sammel MD, Appleby DH, Butts SF. Success of the two-dose methotrexate protocol for treatment of ectopic pregnancy in women with a history of prior ectopic pregnancy. J Reprod Med. 2014 Jul-Aug; 59(7-8):379-84.
Score: 0.116
-
Butts SF, Gibson E, Sammel MD, Shaunik A, Rudick B, Barnhart K. Race, socioeconomic status, and response to methotrexate treatment of ectopic pregnancy in an urban population. Fertil Steril. 2010 Dec; 94(7):2789-92.
Score: 0.022
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|